Neuromorphological background of cannabis addictionWENGER, Tibor; MOLDRICH, Gabriella; FURST, Susanna et al.Brain research bulletin. 2003, Vol 61, Num 2, pp 125-128, issn 0361-9230, 4 p.Article

(+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity onlyFRIDE, Ester; FEIGIN, Cfir; PONDE, Datta E et al.European journal of pharmacology. 2004, Vol 506, Num 2, pp 179-188, issn 0014-2999, 10 p.Article

The diverse CB₁ and CB₂ receptor pharmacology of three plant cannabinoids : Δ⁹-tetrahydrocannabinol, cannabidiol and Δ⁹-tetrahydrocannabivarinPERTWEE, R. G.British journal of pharmacology. 2008, Vol 153, Num 2, pp 199-215, issn 0007-1188, 17 p.Article

Targeting the cannabinoid CB2 receptor : modelling and structural determinants of CB2 selective ligandsPOSO, A; HUFFMAN, J. W.British journal of pharmacology. 2008, Vol 153, Num 2, pp 335-346, issn 0007-1188, 12 p.Article

Variations in the cannabinoid receptor 1 gene predispose to migraineJUHASZ, Gabriella; LAZARY, Judit; ANDERSON, Ian M et al.Neuroscience letters. 2009, Vol 461, Num 2, pp 116-120, issn 0304-3940, 5 p.Article

Sch35966 is a potent, selective agonist at the peripheral cannabinoid receptor (CB₂) in rodents and primatesGONSIOREK, W; LUNN, C. A; FAN, X et al.British journal of pharmacology. 2007, Vol 151, Num 8, pp 1262-1271, issn 0007-1188, 10 p.Article

Pharmacological actions of cannabinoidsPERTWEE, R. G.Handbook of experimental pharmacology. 2005, Vol 168, pp 1-51, issn 0171-2004, 51 p.Article

Desulfohaplosamate, a new phosphate-containing steroid from Dasychalina sp., is a selective cannabinoid CB2 receptor ligandCHIANESE, Giuseppina; FATTORUSSO, Ernesto; TAGLIALATELA-SCAFATI, Orazio et al.Steroids. 2011, Vol 76, Num 10-11, pp 998-1002, issn 0039-128X, 5 p.Article

Characterization of the pharmacology of imidazolidinedione derivatives at cannabinoid CB₁ and CB₂ receptorsGOVAERTS, Sophie J; MUCCIOLI, Giulio G; HERMANS, Emmanuel et al.European journal of pharmacology. 2004, Vol 495, Num 1, pp 43-53, issn 0014-2999, 11 p.Article

No association of CNR1 gene variations with susceptibility to schizophreniaSEIFERT, Jürgen; OSSEGE, Sebastian; EMRICH, Hinderk M et al.Neuroscience letters. 2007, Vol 426, Num 1, pp 29-33, issn 0304-3940, 5 p.Article

5-Sulfonyl-benzimidazoles as selective CB2 agonists-Part 2GIJSEN, Harrie J. M; DE CLEYN, Michel A. J; SURKYN, Michel et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 1, pp 547-552, issn 0960-894X, 6 p.Article

Evidence for both inverse agonism at the cannabinoid CB₁ receptor and the lack of an endogenous cannabinoid tone in the rat and guinea-pig isolated ileum myenteric plexus-longitudinal muscle preparationMAKWANA, R; MOLLEMAN, A; PARSONS, M. E et al.British journal of pharmacology. 2010, Vol 160, Num 3, pp 615-626, issn 0007-1188, 12 p.Article

Activation of CB₁ and CB₂ receptors attenuates the induction and maintenance of inflammatory pain in the ratELMES, Steven J. R; WINYARD, Lisa A; MEDHURST, Stephen J et al.Pain (Amsterdam). 2005, Vol 118, Num 3, pp 327-335, issn 0304-3959, 9 p.Article

CANNABINOID RECEPTOR CB1 ANTAGONISTS: STATE OF THE ART AND CHALLENGESBIFULCO, Maurizio; SANTORO, Antonietta; LAEZZA, Chiara et al.Vitamins and hormones. 2009, Vol 81, pp 159-189, issn 0083-6729, 31 p.Article

The effect of cannabinoid receptor antagonism with SR141716A on antinociception induced by cocaine and the NMDA receptor antagonist, MK-801FORMAN, Lloyd J.Brain research bulletin. 2003, Vol 61, Num 2, pp 153-158, issn 0361-9230, 6 p.Article

Pre-emptive antinociceptive effects of a synthetic cannabinoid in a model of neuropathic painGUINDON, Josée; DESROCHES, Julie; DANI, Mélina et al.European journal of pharmacology. 2007, Vol 568, Num 1-3, pp 173-176, issn 0014-2999, 4 p.Article

CB1 AND CB2 CANNABINOID RECEPTOR EXPRESSION DURING DEVELOPMENT AND IN EPILEPTOGENIC DEVELOPMENTAL PATHOLOGIESZUROLO, E; IYER, A. M; SPLIET, W. G. M et al.Neuroscience. 2010, Vol 170, Num 1, pp 28-41, issn 0306-4522, 14 p.Article

Endocannabinoids as positive or négative factors in hematopoietic cell migration and differentiationPATINKIN, Deborah; MILMAN, Garry; BREUER, Aviva et al.European journal of pharmacology. 2008, Vol 595, Num 1-3, pp 1-6, issn 0014-2999, 6 p.Article

Therapeutic potential of cannabinoid receptor ligands : Current statusSINGH, J; BUDHIRAJA, S.Methods and findings in experimental and clinical pharmacology. 2006, Vol 28, Num 3, pp 177-183, issn 0379-0355, 7 p.Article

Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory painGUINDON, Josée; DE LEAN, André; BEAULIEU, Pierre et al.Pain (Amsterdam). 2006, Vol 121, Num 1-2, pp 85-93, issn 0304-3959, 9 p.Article

Cannabinoid receptors and the regulation of bone massBAB, I; ZIMMER, A.British journal of pharmacology. 2008, Vol 153, Num 2, pp 182-188, issn 0007-1188, 7 p.Article

Cannabinoid Type 1 Receptor : Another Arrow in the Adipocytes' BowBELLOCCHIO, L; CERVINO, C; VICENNATI, V et al.Journal of neuroendocrinology. 2008, Vol 20, pp 130-138, issn 0953-8194, 9 p., SUP1Conference Paper

Cannabinoid receptor ligands suppress memory-related effects of nicotine in the elevated plus maze test in miceBIALA, Grazyna; KRUK, Marta.Behavioural brain research. 2008, Vol 192, Num 2, pp 198-202, issn 0166-4328, 5 p.Article

Récepteurs cannabinoïdes: Fonctions cellulaires = Cannabinoid receptors : cellular functionsBOUABOULA, M; CASELLAS, P.Douleur et analgésie. 2001, Vol 14, Num 4, pp 207-211, issn 1011-288XArticle

Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB₁ receptorCHEN, Richard Z; FRASSETTO, Andrea; FONG, Tung M et al.European journal of pharmacology. 2008, Vol 584, Num 2-3, pp 338-342, issn 0014-2999, 5 p.Article